UPDATE: JP Morgan Initiates Greenway Medical Technologies at Overweight on Platform Quality
JP Morgan initiated coverage on Greenway Medical Technologies (NYSE: GWAY) with an Overweight rating and a $19 price target.
JP Morgan noted, "We are initiating coverage on Greenway (GWAY) with an Overweight rating as we believe the company has a highly rated, differentiated platform from which to gain additional EMR, RCM and PM customers. Additionally, we believe Greenway's pro-active partnerships with enterprise EHRs provide an advantage for physicians."
Greenway Medical Technologies closed at $15.98 on Wednesday.
Latest Ratings for GWAY
|Sep 2013||Raymond James||Downgrades||Strong Buy||Market Perform|
|Sep 2013||William Blair||Downgrades||Outperform||Market Perform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.